Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 670

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 2
Chunk 670
---
    recommendations to the board of directors regarding compensation for non-employee directors, and review periodically non- employee
    director compensation in relation to other comparable companies and in light of such factors as the compensation committee may deem
    appropriate; and

    ●
    review
    periodically reports from management regarding funding the Company’s pension, retirement, long-term disability and other management
    welfare and benefit plans.

Nominating
and Corporate Governance Committee

The
nominating and corporate governance committee, which consists of Joshua Schafer (Chair), Steve Richards and Bette Jacobs, recommends
to the board of directors individuals qualified to serve as directors and on committees of the board of directors to advise the board
of directors with respect to the board of directors composition, procedures and committees to develop and recommend to the board of directors
a set of corporate governance principles applicable to the Company, and to oversee the evaluation of the board of directors and the Company’s
management. In addition, the nominating and corporate governance committee will consider diversity of background including diversity
of race, ethnicity, international background, gender and age when evaluating candidates for board of directors membership.

Further,
the nominating and corporate governance committee, to the extent it deems necessary or appropriate, among its several other responsibilities
will:

    ●
    recommend
    to the board of directors and for approval by a majority of independent directors for election by stockholders or appointment by
    the board of directors as the case may be, pursuant to our bylaws and consistent with the board of director’s evidence for
    selecting new directors;

    ●
    review
    the suitability for continued service as a director of each member of the board of directors when his or her term expires or when
    he or she has a significant change in status;

    ●
    review
    annually the composition of the board of directors and to review periodically the size of the board of directors;

    ●
    make
    recommendations on the frequency and structure of board of directors meetings or any other aspect of procedures of the board of directors;

    ●
    make
    recommendations regarding the chairmanship and composition of standing committees and monitor their functions;

    ●
    review
    annually committee assignments and chairmanships;

    ●
    recommend
    the establishment of special committees as may be necessary or desirable from time to time; and

    ●
    develop
    and periodically review corporate governance procedures and consider any other corporate governance issue.

Code
of Ethics

We